bortezomib

Generic: bortezomib

Labeler: zydus pharmaceuticals usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bortezomib
Generic Name bortezomib
Labeler zydus pharmaceuticals usa inc.
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS SUBCUTANEOUS
Active Ingredients

bortezomib 1 mg/mL

Manufacturer
Zydus Pharmaceuticals USA Inc.

Identifiers & Regulatory

Product NDC 70710-1411
Product ID 70710-1411_1d5e9573-97a5-4d8e-a9b1-80750b9870b3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210204
Listing Expiration 2026-12-31
Marketing Start 2022-05-02

Pharmacologic Class

Established (EPC)
proteasome inhibitor [epc]
Mechanism of Action
proteasome inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 707101411
Hyphenated Format 70710-1411

Supplemental Identifiers

RxCUI
402243
UNII
69G8BD63PP
NUI
N0000175604 N0000175075

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bortezomib (source: ndc)
Generic Name bortezomib (source: ndc)
Application Number ANDA210204 (source: ndc)
Routes
INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 1 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1411-1) / 3.5 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

70710-1411-1 1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1411-1) / 3.5 mL in 1 VIAL, SINGLE-DOSE

Ingredients (1)

bortezomib (1 mg/mL)

Linked Drug Pages (1)

BORTEZOMIB ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "1d5e9573-97a5-4d8e-a9b1-80750b9870b3", "openfda": {"nui": ["N0000175604", "N0000175075"], "unii": ["69G8BD63PP"], "rxcui": ["402243"], "spl_set_id": ["0eb8daef-18da-43bb-b7c6-38c4c8b5dd80"], "pharm_class_epc": ["Proteasome Inhibitor [EPC]"], "pharm_class_moa": ["Proteasome Inhibitors [MoA]"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1411-1)  / 3.5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "70710-1411-1", "marketing_start_date": "20220502"}], "brand_name": "BORTEZOMIB", "product_id": "70710-1411_1d5e9573-97a5-4d8e-a9b1-80750b9870b3", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Proteasome Inhibitor [EPC]", "Proteasome Inhibitors [MoA]"], "product_ndc": "70710-1411", "generic_name": "BORTEZOMIB", "labeler_name": "Zydus Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BORTEZOMIB", "active_ingredients": [{"name": "BORTEZOMIB", "strength": "1 mg/mL"}], "application_number": "ANDA210204", "marketing_category": "ANDA", "marketing_start_date": "20220502", "listing_expiration_date": "20261231"}